TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
3 hedge funds and large institutions have $1.17M invested in TrovaGene, Inc. Warrant in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
36% less capital invested
Capital invested by funds: $1.81M → $1.17M (-$649K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$296 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $1.16M | +$296 | +100 | +0% |
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$2.07K | +699 | New |
|
TROVW Hedge Fund Activity: Q4 2014 in Review
3 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q4 2014, worth a combined $1.17M — down 36% from $1.81M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TROVW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, adding an estimated $296.
- 3 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $1.17M of TrovaGene, Inc. Warrant stock for Q4 2014, down 36% quarter-over-quarter.
- 1 fund opened new TrovaGene, Inc. Warrant positions in Q4 2014 and 0 closed out, a net change of +1 holder.
- The largest TrovaGene, Inc. Warrant buyer in Q4 2014 was Millennium Management, an estimated $296 added.
Based on aggregated 13F filings for Q4 2014.